Evidence map›Paper›PMID 42333271›Full record

ArticleBiology methods & protocols2026

Assessing the feasibility of machine learning for ancient DNA age prediction: Limitations and insights.

Maksim Kazanskii, Maria Golikova, Artem Kasianov, Anna Ivanova, Alibek Suraganov, Leonid Uroshlev

Abstract read
In one paragraph

Article in Biology methods & protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maksim KazanskiiIndependent Researcher.ORCID https://orcid.org/0009-0005-6822-3520
Maria GolikovaIndependent Researcher.
Artem KasianovEvolutionary Approaches to Human Genetic and Cultural Diversity, BIOPOLIS/CIBIO, Campus de Vairão, Universidade do Porto, 4485-661, Porto, Portugal.
Anna IvanovaIndependent Researcher.
Alibek SuraganovIndependent Researcher.
Leonid UroshlevLaboratory of Strucural Biology, L.A. Orbeli Institute of Physiology NAS RA, Orbeli Bros. str. 0028, Yerevan, Armenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the possibility of estimating the age of ancient biological samples directly from their DNA damage profiles using supervised machine learning. Traditional dating methods such as radiocarbon dating or dendrochronology rely on either isotope composition or material context, while our approach exploits intrinsic molecular degradation signatures. Using damage statistics obtained from ancient DNA sequencing data, we trained several regression models to predict sample age over a temporal range of up to 10 000 years. Despite initial correlations between specific damage features and age, cross-validation and external testing revealed no statistically significant predictive signal beyond mean-based baselines. These findings indicate that, in the current formulation, DNA damage information alone is insufficient for reliable age estimation. However, this negative result empirically validates the extent to which environmental and biochemical factors dominate damage variation, effectively masking the chronological signal, thereby limiting the predictive power of current supervised learning models. We suggest that integrating contextual data, expanding labeled datasets, and incorporating physical models of DNA decay may improve future attempts. Our study thus contributes to a transparent assessment of the limitations and prospects of DNA-based fossil dating.

Indexed as

age predictionancient DNAbatch effectsDNA damageDNA degradationmachine learningPaleogenomics

Identifiers

PMID42333271
PMCPMC13283477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.